Stuttgart - Delayed Quote • EUR
Syndax Pharmaceuticals Inc (1T3.SG)
At close: April 26 at 10:32 AM GMT+2
Key Executives
Key Executives Information Not Available
Syndax Pharmaceuticals Inc
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
Syndax Pharmaceuticals Inc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Recent Events
Recent Events Information Not Available
Upcoming Events
May 06, 2024 - May 10, 2024
Syndax Pharmaceuticals Inc Earnings Call
Related Tickers
2CL.F BridgeBio Pharma, Inc.
22.83
+3.26%
XUPB.F Genfit S.A.
3.0800
-1.28%
1GDA.BE Zevra Therapeutics Inc
4.2400
+0.95%
CAMXs.XC
AB3A.BE Sarepta Therapeutics Inc
118.45
+2.82%
1AE.SG argenx SE
343.70
-0.75%
GNFTF Genfit S.A.
2.9500
0.00%
20D.F Cidara Therapeutics, Inc.
0.4780
0.00%
UNC.MU UCB SA
124.65
+4.31%
2H51.MU Ocugen Inc
1.1460
-1.55%